Publications by authors named "Medard Ilunga"

Claim this Profile
T
Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study.
Ipos Ngay Lukusa, Nick Van Reet, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, Justin Masumu, Médard Ilunga

EBioMedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard, Victor Kande, Wilfried Mutombo, Medard Ilunga

PLoS Negl Trop Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.
Ipos Ngay Lukusa, Nick Van Reet, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, Justin Masumu, Médard Ilunga

PLoS Negl Trop Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Andrea Kuemmerle, Caecilia Schmid, Victor Kande, Wilfried Mutombo, Medard Ilunga

PLoS Negl Trop Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, Médard Ilunga

Lancet· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
Caecilia Schmid, Andrea Kuemmerle, Johannes Blum, Salah Ghabri, Victor Kande, Medard Ilunga

PLoS Negl Trop Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.
Stijn Deborggraeve, Veerle Lejon, Rosine Ali Ekangu, Dieudonné Mumba Ngoyi, Patient Pati Pyana, Médard Ilunga

PLoS Negl Trop Dis· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness.
Dieudonné Mumba Ngoyi, Veerle Lejon, Pati Pyana, Marleen Boelaert, Médard Ilunga

J Infect Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Gerardo Priotto, Serena Kasparian, Wilfried Mutombo, Daniel Ngouama, Sara Ghorashian, Médard Ilunga

Lancet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis